Erweiterte Suche

Geoffrey P. Doherty bekleidet die Position des Chief Financial Officer & Executive Director bei der Kingspan Group Plc. Zuvor war Herr Doherty Chief Financial Officer bei der Greencore Group Plc.

Derzeit bekleidet Edmund Doherty die Position des Vice President-Medical Affairs bei Reata Pharmaceuticals, Inc. Er erhielt einen Doktortitel von der Creighton University.

Gegenwärtig ist James Doherty Chief Research Officer bei SAGE Therapeutics, Inc. In seiner früheren Karriere hatte er die Position des Director & Head-Neuroscience bei AstraZeneca Pharmaceuticals AB und des Director & Head-Neuroscience Department bei AstraZeneca Pharmaceuticals LP inne. James Doherty erhielt einen Undergraduate-Abschluss von der University of Delaware und einen Doktortitel von der Georgetown University.

David T.
Doherty is currently the Chief Financial Officer & Executive Vice President at Surgery Partners, Inc. He previously worked at Aetna, Inc. as an Assistant Controller.

William J. Dohert bekleidet die Position des Senior VP & Group GM-Information Communications bei Amphenol Corp. In seiner früheren Karriere hatte Herr Doherty die Position des Vice President-Operations bei Astral Point Communications, Inc. inne. Herr Doherty erhielt einen MBA von der University of Massachusetts und einen Bachelor-Abschluss vom Wentworth Institute of Technology.

Derzeit ist Geoffrey Bouquot VP-Strategy & External Relations bei Valeo SA. Er erhielt einen Bachelor-Abschluss von der Ecole Polytechnique und einen Bachelor-Abschluss von der Cole Nationale Suprieure des Mines de Paris.

Geoffrey Price gründete Oak Street Health, Inc. Derzeit ist er Chief Operating Officer & Director bei diesem Unternehmen. In der Vergangenheit war er als Principal bei Bain & Co, Inc. und als Associate bei Nautic Partners LLC tätig. Er erhielt einen MBA von der Harvard Business School und einen Bachelor-Abschluss von der University of Illinois.

Geoffrey William Guy gründete GW Pharmaceuticals Plc, Amarin Corp. Plc und Phytopharm Plc. Derzeit hat er die Position des Vorsitzenden von GW Pharmaceuticals Plc inne. Dr. Guy ist auch im Vorstand von GW Research Ltd., GW Pharma Ltd. und The Chedington Court Estate Ltd. sowie Mitglied der Royal Society of Medicine und Mitglied des Royal College of Surgeons of England. In der Vergangenheit hatte Dr. Guy die Position des Chairman & Chief Executive Officer bei Amarin Corp. Plc, Chairman für Phytopharm Plc und Director-Clinical Development bei Napp Laboratories Ltd. Er erhielt einen Bachelor-Abschluss von der University of London und einen Doktortitel vom St Bartholomew's Hospital Medical College.

Geoffrey Howard Babidge is currently a Director in multiple companies including The a2 Milk Company (Australia) Pty Ltd, a2 Holdings UK Ltd, a2 Australian Investments Pty Ltd, a2 Botany Pty Ltd, a2 Infant Nutrition Ltd, The a2 Milk Company (Export) Ltd, a2 Infant Nutrition Australia Pty Ltd, a2 Exports Australia Pty Ltd, A2 Dairy Products New Zealand Ltd, and The a2 Milk Co. Ltd.
(Canada).
In the past, he served as the Chief Executive Officer, Executive Director & MD of The a2 Milk Co. Ltd.
from 2010 to 2018.
He was also a Non-Executive Director of Noumi Ltd.
from 2012 to 2013 and a Partner at PricewaterhouseCoopers New Zealand.
Additionally, he held positions as a Director in The a2 Milk Co. Ltd.
(United Kingdom) and The a2 Milk Company (New Zealand) Ltd.
and was the Managing Director of National Food Ltd.

Geoffrey Arthur Ballotti ist ein Geschäftsmann, der bereits 11 verschiedene Unternehmen geleitet hat. Derzeit hat Herr Ballotti die Position des President, Chief Executive Officer & Director bei Wyndham Hotels & Resorts, Inc. und President & Chief Executive Officer für Wyndham Hotel Group LLC, Chief Executive Officer von Super 8 Worldwide, Inc. und President & Chief Executive Officer bei Wyndham Hotels & Resorts LLC, Chief Executive Officer von Hawthorn Suites Franchising, Inc. und President von Howard Johnson International, Inc. (die alle Tochtergesellschaften von Wyndham Hotels & Resorts, Inc. sind) und Chief Executive Officer für die Group RCI, Inc. Geoffrey Arthur Ballotti ist außerdem Mitglied des Vorstands der American Hotel & Lodging Association, Inc. (ehemaliger Vorsitzender) und Geschäftsführer bei Compagnia Italiana Grandi Alberghi CIGA SPA. In der Vergangenheit war Herr Ballotti President & Chief Executive Officer für Wyndham Exchange & Rentals, Chief Executive Officer für Wyndham Destination Network LLC, President-North American Division bei Starwood Hotels & Resorts Worldwide LLC und Vorsitzender der U.S. Travel Association. Geoffrey Arthur Ballotti erwarb einen Bachelor-Abschluss an der Harvard University.

Der Gründer von First Quantum Minerals Ltd., Geoffrey Clive Newall, ist derzeit President & Director bei diesem Unternehmen. Herr Newall ist auch im Vorstand von Marimaca Copper Corp. und First Quantum Minerals (UK) Ltd. In der Vergangenheit war Herr Newall Principal bei Amax Exploration, Inc. sowie Research Analyst bei Smith New Court Plc und Principal bei Robertson Group Ltd. Herr Newall erhielt einen Bachelor-Abschluss von der Royal School of Mines.

Geoffrey E. Molson ist eine Geschäftsperson, die an der Spitze von 7 verschiedenen Unternehmen gestanden hat und derzeit die Position des Vorsitzenden der Groupe Juste Pour Rire, Inc. innehat, Präsident & Chief Executive Officer für den Club de hockey Canadien, Inc. ist, Eigentümer des Montreal Canadiens Hockey Club (eine Tochtergesellschaft des Club de hockey Canadien, Inc.), Präsident & Chief Executive Officer von L'Arna des Canadiens, Inc. ist, Präsident & Chief Executive Officer der CH Group LP ist und Präsident & Chief Executive Officer des Bell Center ist. Geoffrey E. Molson ist auch im Vorstand von Molson Coors Beverage Co. (ehemaliger stellvertretender Vorsitzender), Molson Coors Canada, Inc. und der National Hockey League sowie Präsident & Chief Executive Officer von Evenko, Inc. und Mitglied der The Molson Family Foundation, Mitglied der Montreal Canadiens Children's Foundation, Mitglied der St. Mary's Hospital Foundation (Kanada) und Eigentümer des Montreal Canadiens Hockey Club. In seiner bisherigen Laufbahn war Geoffrey E. Molson Global Assistant-Media Services bei The Coca-Cola Co., Vice President-Marketing bei Molson ULC, Vice President-Sales & Marketing bei Molson USA und Vice-President-Marketing bei Molson Brewery BC Ltd. Geoffrey E. Molson erhielt einen Undergraduate-Abschluss von der St. Lawrence University und einen MBA vom Babson College.

Geoffrey King is currently the Chief Executive Officer at The Food Purveyor Sdn.
Bhd.
and a Director at GNC Group Consulting Pty Ltd.
He previously worked as the Chief Financial Officer at Tesco Plc, Group Chief Financial Officer at Maxis Communications Bhd., and Chief Financial Officer at Tesco Polska Sp zoo and Tesco Ireland Ltd.
He also served as an Independent Member-Supervisory Board at X5 Retail Group NV.
Mr. King received his undergraduate degree from The University of Exeter.

Herr Geoffrey Drabble ist Chairman bei DS Smith Plc, Chairman bei Ferguson Plc und Senior Independent Director bei Howden Joinery Group Plc. Er ist Mitglied des Board of Directors bei Howden Joinery Group Plc und Ferguson Group Holdings. Herr Drabble war zuvor als Chairman bei Ferguson Holdings Ltd., als Chief Executive Officer & Executive Director bei Ashtead Group Plc. und als Executive Director bei Laird Ltd. tätig. Er war auch im Vorstand von Ashtead Holdings Plc und Ashtead Plant Hire Co. Ltd.

Geoffrey William Squire is currently the Executive Chairman at Kognitio Ltd., Chairman at Give as you Live Ltd., and Director at Kognitio Holdings Ltd.
He previously held positions as the Chief Executive Officer at Openvision Technologies, Inc., Vice Chairman at VERITAS Software Corp., Non-Executive Chairman at The Innovation Group Ltd., and Independent Director at Informatica LLC.
He also held positions at Oracle Corp., Computing Services & Software Association Ltd., and The European Association of Information Services.

Herr Geoffrey Wild ist Chief Executive Officer bei Atotech USA, Inc. und Chief Executive Officer bei Atotech BV, Chief Executive Officer & Managing Director bei Atotech Deutschland GmbH, Independent Director bei Cabot Microelectronics Corp. und President, Chief Executive Officer & Director bei Atotech Ltd. Er ist Mitglied des Board of Directors bei Cabot Microelectronics Corp., Atotech UK Topco Ltd. und Atotech Ltd. Herr Wild war zuvor als unabhängiger Director bei Materion Corp., als Chief Executive Officer bei AZ Electronic Materials Holdings SA, als Chief Executive Officer & Executive Director bei AZ Electronic Materials SA, als President & Chief Executive Officer bei Cascade Microtech, Inc., als unabhängiger Non-Executive Director bei E Ink Corp., als President & Chief Executive Officer bei Nikon Precision, Inc., als President-Electronics Materials Business bei Honeywell International LLC und als Chief Executive Officer bei TheSupply, Inc. tätig. Er war auch im Vorstand von Axcelis Technologies, Inc. Seinen Bachelor-Abschluss machte er an der University of Bath.

Dr. Geoffrey M. Duyk ist Chairman bei Amyris, Inc. und Managing Director bei TPG Biotech Equity LP, Managing Director & Partner bei Tarrant Capital IP LLC, Managing Partner bei Circularis Partners LP und Mitglied des National Human Genome Research Institute. Er ist Mitglied des Board of Directors von Anuvia Plant Nutrients Corp, Concentric Ag Corp, Concentric Agriculture, Inc, H. Lee Moffitt Cancer Center & Research Institute, Inc, Innovatus Life Sciences Acquisition Corp, Regen Holdings Ltd, White's Recycling Ltd, Whites Engineering Ltd. und Case Western Reserve University. Dr. Duyk war zuvor als unabhängiger Direktor bei EPIRUS Biopharmaceuticals, Inc. tätig, als unabhängiger Direktor bei Zalicus, Inc., als Partner bei TPG Alternative & Renewable Technologies, als Treuhänder bei der Wesleyan University, als unabhängiger Direktor bei Aerie Pharmaceuticals, Inc, ein Director, President-Research & Development von Exelixis, Inc. ein Vice President-Genomics von Takeda Oncology Co. ein Member-SAB von Bayer CropScience, Inc. und ein Assistant Professor von der Harvard Medical School. Darüber hinaus war er Vorstandsmitglied bei Genomatica, Inc, Beta Renewables SpA, DNAnexus, Inc, Karos Pharmaceuticals, Inc, Elevance Renewable Sciences, Inc, Agria Corp, Galleon Pharmaceuticals, Inc, Replidyne, Inc, Cardiovascular Systems, Inc, American Society of Human Genetics, Avidia, Inc, FoldRx Pharmaceuticals, Inc, MacroGenics, Inc, moksha8 Pharmaceuticals, Inc, Regen Devco Ltd. und Shangpharma Corp. Er erhielt seinen Undergraduate-Abschluss von der Wesleyan University und einen Doktortitel von der Case Western Reserve University.

Herr Geoffrey S. Davis, CFA, ist Chief Financial Officer & Director bei Studio City International Holdings Ltd, Chief Financial Officer bei Melco International Development Ltd, Chief Financial Officer & Executive Vice President bei Melco Resorts & Entertainment Ltd. und Chief Financial Officer & Director bei Studio City Finance Ltd. Er ist Mitglied des Board of Directors von Studio City International Holdings Ltd., Melco Resorts & Entertainment (Philippines) Corp., Studio City Finance Ltd. und ICR Cyprus Holdings Ltd. Herr Davis war zuvor als Vice President-Corporate Communications bei Park Place Entertainment Corp. und als Research Analyst bei Citigroup Global Markets, Inc. (Broker). Er erhielt seinen Bachelor-Abschluss von der Brown University.

Geoffrey Thomas Martin bekleidet die Position des President, Chief Executive Officer & Director bei CCL Industries, Inc. und Chief Executive Officer & Director bei Checkpoint Systems, Inc. und President für Banknote Corporation of America, Inc. (beides sind Tochtergesellschaften von CCL Industries, Inc.). Herr Martin ist außerdem im Vorstand von 15 weiteren Unternehmen. In der Vergangenheit hatte er die Position des Senior Group Vice President-Worldwide Converting bei Avery Dennison Corp. und des Präsidenten bei CCL Label inne.

Herr Geoffrey T. Barker ist Vorsitzender bei Laird Superfood, Inc. und Vorsitzender bei Smartsheet, Inc. Er ist Mitglied des Verwaltungsrats von Zipwhip, Inc. und Special X, Vimly, Inc. sowie von Eden Reforestation Projects, Light & Motion Industries, Tell Friends, Inc. und Wisdo, Inc. Herr Barker war zuvor als Executive Director bei RPX Corp., als Vice President-Licensing bei Intellectual Ventures Management LLC, als Chairman & Chief Executive Officer bei Vigilos, Inc., als Co-Chief Executive Officer bei Cobalt Group, Inc., als Mitbegründer bei Harvestwest Investments LLC, als Principal bei Kidder, Peabody & Co, Inc., als Investmentbanker bei Piper Sandler & Co. und als Investmentbanker bei Salomon Brothers tätig. Er war auch im Vorstand von OceanGate, Inc. und Tyfone, Inc. Er erhielt seinen Bachelor-Abschluss von der Tufts University und einen MBA von The Trustees of Columbia University in The City of New York.

Geoffrey C.
Haxel worked as a Director at The Pantry, Inc. and as a Manager-Arizona Region at The Circle K Corp.
He also worked as a Vice President-Operations at Alimentation Couche-Tard, Inc. Mr. Haxel completed his undergraduate degree at the University of Oklahoma.

Geoffrey Straub Martha ist Mitglied des Vorstands der Medtronic Communities Foundation, Children's HeartLink, Inc. und der Northside Achievement Zone sowie Chairman & Chief Executive Officer bei Medtronic Plc und President, Chief Executive Officer & Director bei Medtronic, Inc. In seiner früheren Laufbahn war er Chief Executive Officer bei Medina Medical, Inc., Vice President-Business Development bei Potomac Federal, Senior Vice President-Business Development bei GE Capital Vendor Financial Services und Managing Director-Business Development bei GE Healthcare, Inc. Er erwarb einen Bachelor-Abschluss an der Pennsylvania State University.

Gegenwärtig bekleidet Geoffrey M. Nichol die Position des Chief Medical Officer & Senior Vice President bei BioMarin Pharmaceutical, Inc. Dr. Nichol ist außerdem Mitglied des Vorstands von Millendo Therapeutics, Inc. Zuvor war Dr. Nichol als Executive Vice President-Research & Development bei Sangamo Therapeutics, Inc. tätig, als Clinical Research Physician bei GlaxoSmithKline Plc, als Chief Medical Officer bei Ikaria, Inc. als Senior Vice President-Product Development bei Medarex, Inc. und als Head-Global Project Management bei Novartis Pharmaceuticals Corp. Geoffrey M. Nichol erhielt einen MBA von der University of Warwick und einen Doktortitel sowie einen Bachelor-Abschluss von der Dunedin School of Medicine.

Derzeit ist Geoffrey Ian Roberts Group Chief Financial Officer für SEEK Ltd. Herr Roberts ist auch im Vorstand von JB Hi-Fi Ltd., Zhaopin Ltd., AMP Ltd. (Neuseeland) und Online Education Services Pty Ltd. In der Vergangenheit hatte Herr Roberts die Position des Group Chief Financial Officer für AMP AAPH Ltd. inne, war Managing Partner bei Deloitte Touche Tohmatsu Victoria und Vorsitzender der Reach Foundation. Herr Roberts erhielt einen Bachelor-Abschluss von der University of Melbourne und einen MBA von der Australian Graduate School of Management.

Derzeit ist Geoffrey Stecyk Deputy Group CEO-Operations & Technology bei der Ahli United Bank BSC. Zuvor war er Chief Operating Officer bei der National Bank of Ras Al Khaimah, Group Chief Technology Officer bei Malayan Banking Bhd. und Executive Vice President-Business Integration bei Southern Bank Bhd. (Singapur). Er erwarb einen Bachelor-Abschluss an der University of Alberta.

Derzeit ist Geoffrey Peter Martin Group Finance Director & Executive Director bei Melrose Industries Plc. Er ist außerdem im Vorstand von 7 weiteren Unternehmen. In der Vergangenheit war Geoffrey Peter Martin Group Finance Director bei Royal Doulton Ltd., Group Finance Director & Executive Director bei Melrose Plc und Principal bei Coopers & Lybrand (London).

Geoffrey McFarland bekleidet die Position des Director-Group Technology bei Renishaw Plc. Er ist außerdem Mitglied des Vorstands von Cambridge Mechatronics Ltd, PulseTeq Ltd und MTT Technologies Ltd. sowie Mitglied des Institute of Physics (Großbritannien). In seiner früheren Karriere hatte Herr McFarland die Position eines Professors an der Heriot-Watt University inne. Geoffrey McFarland erwarb einen Bachelor-Abschluss an der Heriot-Watt University.

Geoffrey N.
Cornell is currently the Chief Investment Officer of Insurance at AllianceBernstein LP.
Previously, he held positions as a Managing Director at AIG Global Investment Corp.
and PineBridge Investments LLC.
He also served as the Chief Investment Officer-North American Region at American International Group, Inc. from 1994 to 2013.
In addition, he briefly worked as the Chief Investment Officer & Senior Vice President at Corebridge Financial, Inc. in 2022.
Mr. Cornell obtained an MBA from Fordham University and an undergraduate degree from Bryant University.

Brendan Doherty worked as the Head of Corporate Communications at Poniard Pharmaceuticals, Inc.

D.
T.
Brian Doherty was the founder of SignalEnergy, Inc. founded in 2005, where he held the title of Vice President-Exploration.
He is currently an Independent Director at Indigo Exploration, Inc. since 2023 and the President of Valeo Resources LLC since 2012.
Doherty's former positions include being the President, Chief Executive Officer & Director of Cassiar Gold Corp.
from 2010 to 2012, Vice President-Exploration of Predator Exploration Ltd.
in 2004, and Manager-Southern Business Unit of PrimeWest Energy Trust from 2006 to 2008.
Doherty received his undergraduate degree from the University of Windsor in 1980.

Frances P.
Doherty's former job was Vice President-Government Affairs at CareFirst, Inc.

Mark Doherty has held several positions throughout his career.
Currently, he is the Co-Managing Director at Joliette Bâtiments SAS and Vice President-Retail at Chadwick Martin Bailey, Inc. Prior to these roles, he served as the Co-Chief Executive Officer at SAS Parc Des Fontaines.
Doherty received his undergraduate degree from Babson College and his MBA from Northeastern University.

John Doherty worked as a Non-Executive Director at WIMCO Ltd.
and as a Chief Operating Officer at Hollander Home Fashions Corp.

Mr. Robert Doherty is a member of the Strategic Investments Group.
Prior to joining GCM Grosvenor, Mr. Doherty was a Managing Director at JHL Capital Group LLC, where he was responsible for sourcing, executing, and managing public markets investments.
Prior to joining JHL, Mr. Doherty was a Managing Director and Partner at RoundKeep Capital Advisors, LLC.
Prior to joining Roundkeep, Mr. Doherty began his career as an Analyst at Citadel Investment Group in the Principal Strategies Group.
Mr. Doherty received his Bachelor of Science in Economics summa cum laude from The Wharton School of the University of Pennsylvania.

Thomas Doherty is the President & Secretary of Doherty Construction, Inc. since 2008.
He graduated from Arizona State University with an undergraduate degree in 2008.

Mr. Doherty joined Wedge Partners in September 2010.
Prior to that, he was director of sector trading at Pali International, since 2007.
After spending some time at Cantor Fitzgerald, he worked for over a decade at Jefferies and Co., eventually becoming a Vice President and co-manager of the Telco/Media pad.
Mr. Doherty received his BA in Business Management from Fairfield University in 1991.

Bryce Doherty is currently the Director at Financial Services Council since 2020.
Prior to this, he worked at UBS Asset Management (Australia) Ltd.
from 2011 to 2021, where he held the position of Head of Australia & New Zealand from 2013 to 2021.
He also worked at Pendal Group Ltd.
as the Head-Wholesale Sales.

Michael F.
Doherty is a trustee at Doernbecher Children's Hospital Foundation.

Dan Doherty worked as a Partner at Gibraltar Associates LLC from 2011 to 2013.

Daniel Doherty worked as a Manager-National Sales & Marketing at FFI Holdings Ltd.

Mary Elizabeth Doherty is currently serving as an Independent Non-Executive Director at Novartis AG, Independent Member-Supervisory Board at Koninklijke Philips NV, and Independent Member-Supervisory Board at Corbion NV.
She has formerly worked as an Independent Non-Executive Director at Nokia Oyj, Finance Director-Unilever Thai Holdings at Unilever Plc, Director at ABI SAB Group Holding Ltd., Director at Novartis International AG, Senior Independent Director at Dunelm Group Plc, Group Director-International Finance at Tesco Plc, Chief Financial Officer & Director at Reckitt Benckiser Group Plc, Independent Non-Executive Director at Delhaize Le Lion, Chief Financial Officer & Executive Director at Brambles Ltd.
and Reckitt Benckiser Ltd., Non-Executive Director at United Kingdom Ministry of Justice and Her Majesty's Courts & Tribunals Service, Member-Supervisory Board at Agrolimen SA, Chief Financial Officer at Cognita Ltd.
and Mint Hotel Ltd., and Chief Financial Officer at Cognita Schools Ltd.
She completed her undergraduate degree from The University of Manchester.
Currently, Ms. Doherty is serving as an Independent Non-Executive Director at Novartis AG, Independent Member-Supervisory Board at Koninklijke Philips NV, and Independent Member-Supervisory Board at Corbion NV.

Catherine T.
Doherty is currently the Senior Vice President-Regional Businesses at Quest Diagnostics, Inc., the President at Quest Diagnostics Clinical Laboratories, Inc., and the President at Solstas Lab Partners Group LLC.
Previously, she served as the President & Director at Blueprint Genetics, Inc., Summit Health, Inc., and Oracle Diagnostic Laboratories, Inc. Ms. Doherty obtained her undergraduate degree from Montclair State University.

David James Doherty is the founder of Inform Exploration Corp.
(2010), DD Mercantile Corp.
(2007), and Inform Capital Corp.
(2007).
He is currently a Director at Rockshield Acquisition Corp.
(since 2023) and Hempfusion Wellness, Inc. (since 2019).
He has also served as an Independent Director at Black Dragon Gold Corp.
(2010), Eat Well Investment Group, Inc. (2010-2016), Great Northern Gold Exploration Corp.
(2011-2012), OrganiGram Holdings, Inc. (2014-2015), Emblem Corp., BZAM Ltd.
(2016-2018), AbraSilver Resource Corp.
(2017-2018), HempFusion, Inc., and The Green Organic Dutchman Ltd.
Mr. Doherty received an undergraduate degree from Simon Fraser University.

Sean Doherty is the founder of Wurl, Inc. and currently holds the title of Chief Operating Officer at the company.

Sean Doherty is the Founder of the T1D Fund and former Chair of the Board who led the concept-creation, design and capital financing of the Fund, and he has driven its strategy since inception..
Sean retired at the end of 2018 from his role as Managing Director of Bain Capital, LP, a private global investment firm which he joined in 2005 as the firm’s first general counsel.
In this role he built a pioneering and industry-leading deal lawyer and risk management group during a time of rapid growth and institutionalization of the alternative asset industry.
He also had a diverse operational and constituency management role at Bain Capital, where he led crisis management, press and external communications, government relations, branding and philanthropic initiatives and was deeply involved in governance matters and capital raising.
Earlier in his career he worked at Ropes & Gray LLP and was a law clerk to a federal district judge in Boston.
Prior to law school, he was a Lieutenant in the U.S.
Navy, in which he served on a Middle East Force frigate from 1990-94.
Sean and his wife, Suzy, have been involved with JDRF since 2002 when their son Finn was diagnosed with T1D at the age of 2.
He served on the JDRF International Board and its Executive Committee from 2016 to 2019 following more than a decade of service on the JDRF New England Chapter Board, including two years as its President.
He received a J.D.
magna cum laude from Harvard Law School and a B.A.
magna cum laude in Government from Harvard College.
He serves on the boards of directors of two companies with T1D programs and is also a member of the board of trustees of Thayer Academy in Braintree, MA.

Peter Doherty is currently a Director at Three Cheeky Monkeys Holdings Pty Ltd.
and a Principal at Republic Coal Pty Ltd.
He was previously the Non-Independent Executive Chairman at Bellevue Gold Ltd.
from 2013 to 2016.
Mr. Doherty has an undergraduate degree from The University of Sydney and Murdoch University, and an MBA from The Wharton School of the University of Pennsylvania.

Mr. Judson P.
Doherty, CFA, is a President, Chief Executive Officer & Investment Committee Member at Stadion Money Management LLC.
He is on the Board of Directors at Stadion Money Management LLC.
He joined Stadion in 2001 after 10 years in institutional investment consulting.
Under his leadership, Stadion has grown its assets under management.
Mr. Doherty previously served on the Board of Trustees of the Emmanuel Episcopal Endowment Fund, the Board of Governors of the Athens Country Club, and the Board of Directors of the Stadion Classic at UGA golf tournament.
Mr. Doherty was also a member of the Athens Historic Preservation Commission.
He received his Bachelor of Arts degree in Economics from Vanderbilt University and holds the Chartered Financial Analyst designation.

Jim Doherty worked as a Principal at Cisco Systems, Inc. and Symbol Technologies, Inc. He was also a Senior Vice President-Marketing at Ixia and a Chief Operating Officer at Cleartel Communications, Inc. Prior to that, he worked as a Principal at Ericsson Mobile Communications.
He served as a Sergeant at Marine Corps Community Services.
He was also the President & Senior Vice President-Worldwide Sales at QUALCOMM CDMA Technologies and Chief Marketing Officer, SVP-Sales & Marketing at Certes Networks, Inc. He worked as an Executive Vice President-Sales & Marketing at Percona LLC.
Mr. Doherty holds an MBA from Duke University and an undergraduate degree from North Carolina State University.

Colin Scott Doherty's current jobs include being the Chief Executive Officer at Dyn, Inc. since 2016, the Chief Executive Officer at Vercara LLC since 2022, and a Director at Login VSI, Inc., Login VSI BV, Fuze Europe (UK) Ltd., and Wavecrest Management Co LLC.
Mr. Doherty's former jobs include being the President, Chief Executive Officer & Director at BTI Systems, Inc., the Chief Executive Officer at Dynamic Network Services, Inc. from 2016 to 2017, the President & Chief Executive Officer at Mangrove Systems, Inc., the Chief Executive Officer at Arbor Networks, Inc. from 2009 to 2011, the Senior Vice President-Worldwide Sales at NMS Communications Corp., and a Principal at Nortel Networks Corp.Mr. Doherty's education includes an undergraduate degree from the University Of Dundee and a graduate degree from The Chartered Institute of Marketing.

Mr. Doherty served as Vice President with SG Cowen Securities in London, UK providing investment banking services to growth companies throughout Western Europe.
With SG Cowen, Mr. Doherty led the origination and execution of numerous transactions including mergers and acquisitions and public and private equity offerings.
Prior to joining SG Cowen, Mr. Doherty was employed as an Associate with First Union Securities in Charlotte, NC providing investment banking services to financial services clients throughout the United States.
At First Union, Mr. Doherty gained extensive experience in debt underwriting and placement for both regulated and non-regulated competitors in the financial services market including insurance, specialty finance, and employee benefits consulting.
Earlier in his career, Mr. Doherty was employed with International Shipholding Corporation (ISH) in New Orleans, LA and assisted with the management, logistics, and repair and maintenance of ISH’s fleet of 1,800 barges spread throughout North America, Western Europe, East Africa, and Asia.
At ISH, Mr. Doherty worked extensively in project management, marine salvage, contract negotiation and financial analysis.
Mr. Doherty holds an M.B.A.
with honors from Wake Forest University and graduated summa cum laude from Louisiana State University with a B.S.
in Economics.
Mr. Doherty holds Series 7 and 63 securities licenses.

Robert Doherty currently works at Harbor Seafood, Inc., as Controller.